Surgical Wound

Infectious Disease·MeSH: Surgical Wound

11 drugs in development·7 companies·4 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
altrazeal	ULURU INC. (ULU)
HELIOGEN Fibrillar Collagen Matrix	MiMedx Group Inc (MDXG)
ultramist	SANUWAVE Health Inc. (SNWV)

Phase 2(5)

Drug	Company
Ivabradine + Coordinated Care	ADMA BIOLOGICS, INC. (ADMA)
Ivabradine + Usual Care	ADMA BIOLOGICS, INC. (ADMA)
IVIG + Coordinated Care	ADMA BIOLOGICS, INC. (ADMA)
IVIG + Usual Care	ADMA BIOLOGICS, INC. (ADMA)
kio-201	Kiora Pharmaceuticals Inc. (KPRX)

Phase 1(1)

Drug	Company
amicidin-β topical solution -	ADMA BIOLOGICS, INC. (ADMA)

Unknown(2)

Drug	Company
Celularity Placental Matrix (CPM)	Celularity Inc. (CELU)
collagenx	Xtant Medical Holdings, Inc. (XTNT)

BioSniper tracks 11 drugs in development for Surgical Wound across 7 companies.

There are 4 clinical trials targeting Surgical Wound tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.